Recently Viewed
Clear AllUTI Pharma & Healthcare Fund has declared a 20 per cent dividend (i.e. Rs 2.00 per unit on face value of Rs.10). The record date for the dividend is November 21, 2003.This the first dividend payout from the fund.
UTI Pharma & Healthcare Fund, launched in June 1999, exclusively invests in the equities of the Pharma & Healthcare sector companies.
Ask Value Research 
No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.
Welcome to the New Value Research!
2 min read•By Value Research
Value Research Podcast
New episodes every Friday
Who really wins when India invests
The story of India's market is more about participation than prediction
Other Episodes
Crashes are the best classroom
The only way to truly learn investing is to live through the fear and the panic
March has more crises than days
A World Cup win, a war, oil at $119, drones on refineries, a bank chairman's exit and the month isn't over. The morning panic still belongs to borrowed-money investors, not you.
The wait is the work
Why the most painful stretches of a SIP are often the most productive
The oldest disruption in the book
Every oil shock looks permanent at the time. None of them has been.
New Process Alert
Redirecting you to MF Central in
You'll be redirected to MF Central shortly. Complete the process there, then return to Value Research to upload the QR code and finish importing your portfolio.
Still Confused? Read The Quick User Guide
Upload the QR Code
Please upload the QR code downloaded from the MF Central platform in the field provided below
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
Need to Re-Initiate? Go back to MF Central Platform
Complete the 5-step journey
Notifications
Unlock Custom duration
Please subscribe to Value Research Fund Advisor to unlock the custom duration feature and enhance your experience.
Recommendations for the best investments and allocations that are most optimal for your goal
Backed by research by a team of investment experts with over 30 years of experience
Continuous analysis and support from our team to make sure your goals stay on track
Share on Social media
Widely read:
